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Cell-based sensing represents a new paradigm for performing direct and accurate detection of cell- or
tissue-specific responses by incorporating living cells or tissues as an integral part of a sensor. Here we
report a new magnetic cell-based sensing platform by combining magnetic sensors implemented in the
complementary metal-oxide-semiconductor (CMOS) integrated microelectronics process with cardiac
progenitor cells that are differentiated directly on-chip. We show that the pulsatile movements of on-
chip cardiac progenitor cells can be monitored in a real-time manner. Our work provides a new low-
cost approach to enable high-throughput screening systems as used in drug development and hand-
held devices for point-of-care (PoC) biomedical diagnostic applications.
Introduction
There is an unmet need for high-throughput and cost-effective
detection platforms for chemical and biological agents. These
platforms can be utilized for a plethora of analytical and
diagnostic applications including screening chemical libraries for
drug development, toxicity studies, point-of-care (PoC) diag-
nostics, and environmental monitoring. Conventional sensors
generally use chemical, optical, spectroscopic, electrical impe-
dance- or mass-based detection to interpret biochemical phe-
nomena. Cell-based sensing on the other hand makes use of
living cells or tissues as an integral part of the sensor, and utilizes
inherent cellular mechanisms to perform accurate detection of
cell- or tissue-specific responses.1–6 By providing both high
sensitivity and specificity, cell-based sensing has tremendous
potential for screening biochemical agents, particularly in the
context of individualized medicine where effects often vary from
patient to patient.7,8 However, the applications of existing cell-
based sensing platforms are often limited by detection mechan-
isms. For instance, optical detection, though useful in many
applications, requires visible changes in cell morphology, a
transparent medium, and analysis of cell images.6 Moreover,
existing cell-based sensors typically need dedicated device
fabrication processes, which have low scalability and suffer
from low yields in manufacturing. On the other hand, integrated
electronic technology is becoming a powerful and low-cost
platform for implementing advanced sensors. In particular, the
complementary metal-oxide semiconductor (CMOS) process,
which is widely employed in manufacturing consumer electro-
nics, such as microprocessors and memory chips, can be directly
used to realize large biosensor arrays with high scalability at very
low cost.9–27 More importantly, standard CMOS supports
magnetic sensing; it uses magnetic particles as sensing tags,26,27
whose functionality is independent of the optical or electrical
properties of the cells or the medium.28,29 This strategy provides
a robust platform for implementing cell-based sensors.
Here we seek to combine the benefits of CMOS technology
with the advantages of cell-based sensing by developing a new
detection platform based on a CMOS magnetic sensor with
cardiac progenitor cells tagged by magnetic particles. We show
that the cardiac progenitor cells can be differentiated directly on
a CMOS integrated sensor chip to form a cell-based sensor, and
that the periodic and autonomous beating of the progenitors can
be detected in real-time by CMOS magnetic sensing. We further
demonstrate that the sensor enables accurate detection of
chemical agents. The approach described here can be readily
utilized to construct low-cost and field-deployable biochemical
sensors.
Methods and materials
We used cardiac progenitors, differentiated from mouse
embryonic stem cells (ESCs), as the sensing cells. Cardiac
progenitors beat autonomously and undergo displacements of
tens of microns.6 We designed and implemented a fully
integrated inductive frequency-shift magnetic sensor array in a
standard CMOS process.27 With magnetic particles coated on
the cells, the beating movements of the cardiac progenitors can
be accurately captured by the CMOS magnetic sensors without
any post-processing of the data (Fig. 1). If the analyte of interest
alters the physiology of the cells and subsequently their pulsatile
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movements, the changes are readily recorded by the sensor in
real-time.
Preparation of the cardiac progenitor cells
Culturing cardiac progenitors from mouse ESCs. R1 mouse
embryonic stem cells (ESCs) were obtained from ATCC and
propagated in ESC maintenance medium supplemented with
leukemia inhibitory factor (LIF) to maintain their undifferen-
tiated state. The ESC maintenance medium consists of
Dulbecco’s Modified Eagle’s Medium containing 15% of ES
qualified fetal bovine serum (FBS) (16141-061; Gibco), 100 mM
b-mercaptoethanol (M6250; Sigma-Aldrich), 2 mM L-glutamine
(25030-081; Invitrogen Inc.), 0.1 mM nonessential amino acids
(11140-050; Invitrogen Inc.), 1 mM sodium pyruvate (11360-070;
Invitrogen Inc.), 50 U mL21 penicillin and 50 mg mL21
streptomycin (15140-122; Invitrogen Inc.). We supplemented
the ESC maintenance medium with 500 pM murine leukemia
inhibitory factor (LIF) (ESG1107; Millipore). Differentiation
medium had an equivalent composition to ESC maintenance
medium but lacked LIF. We cultured mouse ESCs routinely on
0.2% gelatin-coated tissue-culture flasks and trypsinized them
with 0.05% Trypsin-EDTA (25300062; Gibco) for passaging
purposes. Embryoid bodies (EBs) were made from these cells by
the hanging drop technique.30 Mouse ESCs of passage number
15–20 were used. Differentiation was initiated by resuspension in
differentiation medium lacking LIF. Cells were resuspended at a
density of 500 cells per 20 mL of medium for the hanging drops.
Each hanging drop contained 20 mL of cell suspension.
Direct EB differentiation on the CMOS sensor surface. In order
to yield pulsatile cardiac progenitor cells with high viability and
reliable attachment to the magnetic sensor, we directly differ-
entiated ES cells on the CMOS sensor surface. To minimize
contamination, we first rinsed the chip surface as well as the
PDMS reservoir with 100% ethanol and PBS before surface
modification. Since standard CMOS processes use silicon nitride
as the top passivation layer, to enhance cell attachment to the
silicon nitride surface, we coated the active sensing area (the 64
sensing sites) with 12.5 mg mL21 fibronectin (F1141; Sigma) in
0.02% gelatin at 37 uC and 5% CO2 for 24 h.
31,32 The fibronectin
coating allows integrin receptors on the cell membrane to bind to
the surface, localizes the cells to the active sensing area, and
Fig. 1 Magnetic cell-based sensor. (a) Magnetic particles result in an increased effective inductance Leff in the LC resonator, which causes a downshift
in the resonant frequency. This frequency shift can be detected by the CMOS circuits and serves as the readout for the sensing unit. (b) The normalized
transducer gain (sensitivity to magnetic particles) of the CMOS magnetic sensor is plotted with respect to the sensor inductor geometry. (c) A
spontaneous cardiac cell beating. Inset at top shows the cell potential changes (in milli-volts) during the periodic beating motion. SR = sarcoplasmic
reticulum. (d) Autonomous beating of the cardiac progenitor cells leads to displacements of the magnetic particles and is detected by the CMOS
magnetic sensor as periodic shifts in resonant frequency. (e) The sensor chip contains 64 (8 6 8) independent sensing sites as a sensor array. A zoom-in
view shows the individual sensing site. (f) The sensor module fits in a petri dish. The module includes a PDMS reservoir to hold the cardiac progenitor
cells and the medium. (g) An image of the PDMS sample reservoir shows a cell cluster on the CMOS sensor surface. (h) Diagram for the CMOS
magnetic sensor chip microphotograph, chip system architecture, and the measurement setup.
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increases their adhesion to the sensor. Although the sensor can
be used with cells in suspension, surface attachment of cells to
the sensor area provides for a robust signal by making sure that
small movements of the entire assembly are not registered as cell
movements and that the cells are optimally positioned on the
sensor coils for maximum signal. We seeded the EBs onto the
sensor and incubated the entire assembly at 37 uC and 5% CO2
for ten days in differentiation medium lacking LIF. The medium
was replaced every 24 h. During this time, the EBs proliferated,
attached to the sensor surface, and formed micro-tissues
consisting of cardiac progenitors. The presence of cardiac
progenitors, which formed spontaneously in differentiation
medium, was visually verified.
Coating the cells with magnetic particles. We coated the cardiac
progenitor cells with micron-sized magnetic particles (D =
2.4 mm) to track their pulsatile movements. We used epoxy
functionalized magnetic beads (Dynabead M-270; Invitrogen
Inc). In order to enhance bead attachment to cells, the magnetic
beads were functionalized with fibronectin (F1141; Sigma) by
using an epoxy functionalization kit according to the manufac-
turer’s recommendations (Dynabead M-270; Invitrogen Inc).
After 30 min of attachment, excess beads were removed with
three sequential medium changes. Bead attachment to the
surface of the cells was observed visually by using a stereo
microscope; subsequent medium changes did not alter bead
positions. Visual inspection of the cells showed that on average
10 beads were attached to each cell.
CMOS magnetic sensor for real-time monitoring of cell beating
CMOS magnetic sensor and its implementation. The core of the
CMOS magnetic sensor is an on-chip inductor-capacitor (LC)
resonator.26 When magnetic particles are present, they increase
the total magnetic energy in the space, lead to a change in the
effective inductance in the resonator, and result in a resonant
frequency down-shift (Fig. 1a). The frequency-shift per magnetic
particle can be modelled as the sensor transducer gain and is
designed to present high spatial non-uniformity in our LC
sensing resonator (Fig. 1b). Changes in the cell shape or position
during the sensing process directly cause redistribution of the
attached particles. This spatial distribution leads to variation in
the total resonant frequency-shift and is readily detected by the
CMOS sensor in real-time. Thus, for the autonomous beating of
the cardiac cells in this study, the resulting magnetic sensor
output is a series of periodic pulses (Fig. 1c and 1d). To achieve a
sub-part-per-million (1026) relative frequency-shift sensitivity,
we implemented a low noise on-chip oscillator with Correlated-
Double-Counting (CDC) noise suppression technique for each
LC resonator as the read-out circuits on the CMOS chip.27 The
sensor’s magnetic sensitivity is limited by the noise in the CMOS
electronics. The sensor is capable of detecting a single micron-
size magnetic bead;27 therefore even with very small numbers of
beads on cells, the system is able to detect movement of the cells.
We implemented a magnetic sensor array with 64 independent
sensing sites by paralleling 16 quad-core sensor units each with
4 independent on-chip magnetic sensor sites27 (Fig. 1e). Each
sensor site occupies an area of 120 mm by 120 mm, which is
conducive to cell- or tissue-level detection. By adding more
sensing sites, this architecture enables straightforward extension
to very-large-scale sensor arrays for high throughput applica-
tions, where massively paralleled testing can be used for
characterizing different cell types and testing different chemicals
simultaneously.
The sensor inductor optimization was achieved by using
Ansoft HFSSTM V11 and Ansoft Maxwell1 V10. The CMOS
sensor chip integrated circuits were designed using the Cadence1
Design System as the Electronic Design Automation (EDA)
software. The system’s magnetic detection functionalities and the
digital programmability and real-time data readout were verified
by using simulators of SpectreRF1 and Ultrasim1, respectively.
Finally, we customized the sensor chip for a standard 65 nm
CMOS process fabricated by United Microelectronics Corporation
(UMC).
Assembly of the sensing module. We used a brass substrate as
the base of the sensor module to provide good mechanical
stability, low resistance thermal path, and electrical ground
reference of the sensor chip. The Printed-Circuit-Board (PCB)
was implemented using RT/Duroid1 6010 laminate material
(Rogers Corporation) and was fabricated by DVH Circuit. We
completed the attachment of the CMOS sensor chip, the PCB
board, and the brass substrate by using silver epoxy (H20E,
Epoxy Technology, Inc), which was cured after a 2 h baking at
120 uC. We then used gold wire-bonds to complete the sensor
chip packaging and electrical connections.
In order to hold the sensing cells and the test chemicals, we
constructed a polydimethylsiloxane (PDMS) reservoir on top of
the CMOS sensor chip (Fig. 1f and 1g). GE Silicones1 RTV
615 kit, as the PDMS raw material, was obtained from Applied
Material Tech. We first mixed the PDMS base material and its
curing agent at a 10 : 1 ratio to form the sealing material for the
reservoir. Then, we constructed a cylindrical reservoir from a
short piece of plastic tubing (D = 0.5 cm). The plastic reservoir
was placed over the sensor chip and aligned with the sensing
area. We used the PDMS as adhesive around the reservoir and
thermally cured the entire assembly for one hour at 50 uC.
Preparation of the real-time data acquisition interface. To
control the sensor chip operation and perform data acquisition,
we used an Altera1 DE2 board with Cyclone1 II 2C35 FPGA
core, which directly interfaced with the personal computer as the
measurement console. This setting provides fully reprogram-
mable digital control signals, which were sent to the CMOS
sensor chip to enable the operation of the desired magnetic
sensor sites. The corresponding measured data were directly
acquired also by the FPGA board and subsequently saved on the
personal computer (Fig. 1h). Customized Verilog1 codes were
developed to operate the FPGA board.
Toxicity test of chemical agents
Two sets of chemical sensing experiments were performed to
demonstrate the detection functionality of the magnetic cell-
based sensor in this study. In the first set of experiments,
extracellular ion concentrations were varied independently to
test the corresponding beating frequency changes of the cardiac
progenitor cells. In the second experiment, lidocaine (Sigma) was
This journal is  The Royal Society of Chemistry 2012 Lab Chip, 2012, 12, 4465–4471 | 4467
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used as a small molecule drug, whose effect on the cell beating
amplitude was monitored. The test chemicals were prepared in
the culture medium and directly introduced into the PDMS
chambers on the CMOS magnetic sensors. Before each chemical
was applied, the sensors registered the beating frequency or
amplitude of the cardiac cells under the normal physiological
condition for at least 5 min as the control measurements. These
data were later used as the baseline values for normalization.
Results and discussion
Real-time chemical detection
The magnetic beads were attached to the cardiac progenitor cells
as a one-step preparation procedure before the test chemicals
were introduced and remained bound throughout the measure-
ments. Since no further labelling is needed during the sensing
process for either the sensor or the test chemicals, in this respect
our sensor performs direct detection, similar to the previously
invented method of optical detection of cardiac toxicity on chip.6
Since the CMOS magnetic sensor directly outputs the beating
frequency and amplitude of the cardiac cells, no post-processing
of data is required by our approach, which enables real-time
monitoring during detection. These features of the method
significantly simplify the sample preparation and sensing
procedures, and facilitate highly parallel and low-cost biochem-
ical screening.
Due to the autonomous beating of the cardiac progenitor cells,
the output of the magnetic sensor is a series of periodic pulses,
which we verified to match the beating of the cell cluster. The
signal amplitude of the sensor output is proportional to the
displacement in the pulsatile cell beatings, and the averaged
period between pulses determines the beating frequency of the
cell cluster. Since the cardiac cells beat with a frequency below
1 Hz in our experiments, we set the sensor sampling rate at 20 Hz
to satisfy the Nyquist minimum sampling rate and ensure
accurate amplitude peak recording for the pulsatile waveforms.
As a typical control measurement on the cardiac progenitor cells’
beating rate, we observed a frequency of 0.48 Hz under normal
physiological conditions, i.e. with the extracellular potassium ion
concentration of 3.4 mM (Fig. 2a and 2b).
In addition, we found that differentiation of the EBs directly
on the CMOS sensor surface was more effective in yielding
pulsatile cell clusters compared to seeding the clusters after off-
chip differentiation. Physical disruption in the latter approach,
e.g. with cell scrapers, could abrogate the clusters’ synchronous
motions. We maintained the cells on the sensor surface for up to
15 days without loss of viability or significant morphological
changes. The sensor life-time can potentially be extended by
frequent medium changes and accurate temperature control,
which is important for in-field diagnostic sensors.
Toxicity test of extracellular potassium and calcium ions
Extracellular potassium and calcium ion concentrations have
well-known and significant effects on action potential generation
and thus on the autonomous beating activities of the cardiac
cells. We used different concentrations of these ions for proof-of-
concept testing of the magnetic cell-based sensor functionality.
We dissolved potassium and calcium in the culture media and
prepared the potassium test samples with concentrations of
3.4 mM (normal physiological concentration), 10 mM, and
20 mM and the calcium test samples with concentrations of
2 mM (normal physiological concentration), 4 mM, and 8 mM.
The test chemicals were delivered into the PDMS reservoir by
pipettes.
We first increased the potassium concentration from normal
physiological conditions (3.4 mM) to 10 mM and observed a
corresponding decrease in the recorded pulse frequency from
0.48 Hz to 0.19 Hz (Fig. 2a and 2c). This result verifies that the
recorded frequency shifts were indeed due to the pulsatile
motions of the cardiac progenitors, and is in agreement with
previously reported responses of spontaneously pulsating cardiac
cells.33,34 Since no labelling step was required, the measurement
time was governed by the inherent response time of the cardiac
progenitor cells. We observed a three minute response time to a
shift in potassium ion concentration from 3.4 mM to 10 mM,
which shows fast sample-in-answer-out detection capability.
Increases in the extracellular potassium concentration from
3.4 mM to 10 mM and then to 20 mM resulted in monotonically
reduced pulse frequency until the cells stopped beating (Fig. 3a
and 3b). In addition, we increased the extracellular calcium
concentration from 2 mM to 4 mM and 8 mM, and measured
increases in the pulsatile frequency of the cells by 27% and 46%,
respectively (Fig. 3c and 3d). These observed trends were consistent
with previously reported responses of cardiomyocytes.33,34
Finally, we tested the reversibility of the sensor to show that it
can be restored to its nominal state and reused. We first
increased the extracellular potassium concentration to 20 mM to
stop the autonomous cell movement, and were able to recover
the pulsatile motion by washing the sensor with the cell medium
to return the potassium concentration to its normal physiological
value of 3.4 mM (Fig. 4). In our measurement, two consecutive
washes were needed to adjust the potassium concentration. This
result suggests that the sensor can potentially be reused without
Fig. 2 Real-time sensor response when the extracellular potassium (K+)
level is increased. (a) The recorded sensor response and the correspond-
ing change in the extracellular potassium level. The averaged cell beating
rate stabilizes within 3 min after the K+ level increase, which
demonstrates a fast response time of the cell-based sensor. (b) Zoom-in
plot of the stabilized sensor output in (a) at an extracellular K+ level of
3.4 mM. (c) Zoom-in plot of the stabilized sensor output in (a) at an
extracellular K+ level of 10 mM. (b) and (c) show the steady state sensor
outputs in (a).
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loss of functionality, and further shows the robustness and
potentially extended life-time of the sensor.
Small molecule detection
To test the functionality of the magnetic cell-based sensor in
detecting small molecules, we used lidocaine as a test chemical.
Lidocaine is a small molecule anti-arrhythmic drug that blocks
fast-gated sodium ion channels, impedes the cells from depolar-
izing, and decreases the amplitude of the pulsatile motions.
Due to its rapid onset of action, lidocaine is commonly used
intravenously as an amino amide-type local anesthetic for the
treatment of ventricular arrhythmias.35
We first dissolved lidocaine in cell culture medium at
concentrations of 50 pM and 50 nM. The lidocaine test samples
were then delivered into the sensor PDMS reservoir through
pipettes. With increases in lidocaine concentration to 50 pM and
then to 50 nM, the recorded cell beating amplitudes were reduced
to 89% and 68% of the values observed without lidocaine (Fig. 3e
and 3f). These observations were consistent with the mechanistic
effect of lidocaine.35
The real-time recorded sensor output data in Fig. 5 shows the
cell beating amplitudes with respect to time. We observed that
the beating amplitudes were initially increased after the lidocaine
samples were applied, potentially due to the temperature changes
in the cell medium. The beating amplitudes then gradually
slowed down and stabilized with increasing lidocaine concentra-
tion. The recorded response times were 10 min for 50 pM
lidocaine and 13.8 min for 50 nM lidocaine. These short response
times manifest the fast onset of the lidocaine toxicity effect and
also demonstrate the fast detection capability of the magnetic
cell-based sensor.
Fig. 3 Measurement of the magnetic cell-based sensor steady state outputs. (a) and (b) The real-time measured sensor output and the beating
frequency summary when the cell clusters are subjected to changes in extracellular potassium concentration. Beating rate decreases with an increase in
extracellular potassium level. (c) and (d) The real-time measured sensor output and the beating frequency summary when the cell clusters are subjected
to extracellular calcium concentration changes. The cell pulsatile beating rate is accelerated when the extracellular calcium level is increased. (e) and (f)
The real-time measured sensor output and the beating amplitude summary when lidocaine is added to the cell medium. The amplitude of the cell
beating is reduced at a higher extracellular lidocaine concentration. Error bars represent standard errors.
Fig. 4 Recovery test of the magnetic cell-based sensor. A real-time measured sensor output shows that the autonomous beating of the sensor cells can
be restored. Cell beating stops when the extracellular potassium level is raised to 20 mM, and is then recovered after two washes with the medium
containing 3.4 mM potassium ion. The steady state sensor outputs are highlighted in the boxed regions.
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Conclusions
We have demonstrated a magnetic cell-based sensor that
combines the advantages of a low-cost CMOS microelectronics
manufacturing process and a cell-based sensing scheme with cell-
or tissue-specific responses. Existing biochemical sensing mod-
alities are either incompatible with the CMOS manufacturing
processes or are limited due to their detection requirements. For
example, optical detection methods require visible changes in cell
morphology, can be limited by photo-bleaching, and are difficult
to integrate into compact system.6,9,11 Electrochemical sensing is
sensitive to electrical charge variations at the electrode-electro-
lyte interfaces, and thus experience significant signal drift and
offset due to the measurement background.18–20 In contrast,
magnetic sensing offers unique advantages as a non-optical and
non-contact detection scheme, avoiding all the aforementioned
issues.21–27 Moreover, since most biological samples and media
are magnetically transparent, a low background noise level and
reduced off-target effects are obtained.28,29 More importantly,
the CMOS magnetic sensor can be manufactured at low cost and
for large production volumes.
Depending on the application of interest, our magnetic cell-
based sensor can be outfitted with a variety of cell types with
diverse functionalities. Mouse ESCs are particularly suitable for
building high-throughput cell-based sensors in large volume,
since they can be readily expanded to large numbers and
differentiated to various cell types. The direct on-chip differ-
entiation of mouse ESCs substantially simplifies the required
preparation and handling steps, and further benefits mass
production of the magnetic cell-based sensor.
In this study, the physical movement of the cardiac progenitor
cells, i.e. pulsatile motion, was used as a robust detection signal;
this movement could also take other forms, such as cell
migration, for implementing similar cell-based sensing platforms.
Moreover, sensor cells can be genetically modified to increase
sensitivity and selectivity to certain chemical stimuli, thereby
enhancing the functionality of the cell-based sensor.
Since this magnetic cell-based sensor does not require labelling
during the measurement, it enables fast sample-in-answer-out
chemical detection. Measurement times are limited only by the
response time of the cells and can be as fast as three minutes as
shown here. The long sensor life-time and high level of robustness
should make these systems useful for in-field diagnostic applica-
tions. Cell proliferation may potentially be measured by this
system by tracking long-term changes in positions of magnetic
beads. Since cell proliferation occurs on time scales much longer
than those of pulsatile motions, the sensor makes accurate
measurements in the presence of cell proliferation. The most
important limitations of this sensor technology arise from the
need to maintain the sensing unit under physiological conditions.
Several implementation refinements can be made to the sensor
to achieve a complete lab-on-chip system. A microfluidic
structure can be easily included to standardize sample delivery
and medium exchange, and to provide the parallel detection
chambers required for high-throughput chemical screening.26,36,37
Temperature regulators can be integrated into the CMOS circuit
to accurately control the local or global thermal environment on
the sensor,26,38 and to extend the long-term viability of the sensor
cells with no need for any external heating devices.
In conclusion, our magnetic cell-based sensing platform
provides a compact solution for rapid and real-time detection
of biochemical agents. Based on this method, it is possible to
construct fully portable chemical sensors. This approach may
greatly reduce the cost of high-throughput screening systems in
drug development and also enable hand-held devices for point-
of-care (PoC) diagnostic applications, such as epidemic disease
control and environmental monitoring.
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